Dominik Paquet

Title: Dominik Paquet: Innovator in CRISPR Gene Editing

Introduction

Dominik Paquet is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of gene editing, particularly through his work on CRISPR technology. His innovative approach has the potential to enhance the precision and effectiveness of genetic modifications.

Latest Patents

Dominik Paquet holds a patent titled "Enhancement of CRISPR gene editing or target destruction by co-expression of heterologous DNA repair protein." This patent provides compositions, methods, and kits aimed at improving CRISPR-based editing of DNA targets by utilizing a CRISPR-associated (Cas) enzyme. The enhancement is achieved by combining the Cas enzyme and a CRISPR targeting RNA with a heterologous DNA repair enzyme, which may include RecBCD, AddAB, or AdnAB. Notably, the heterologous DNA repair enzyme can have inactivated nuclease activity. The method also incorporates the use of a DNA repair template to introduce changes into the edited DNA, and it includes cells containing components of the improved CRISPR systems, as well as kits for creating such cells.

Career Highlights

Dominik Paquet is affiliated with The Rockefeller University, where he continues to advance research in gene editing technologies. His work has garnered attention for its innovative approach to enhancing CRISPR systems, making significant strides in the field of genetic engineering.

Collaborations

Dominik collaborates with notable scientists such as Luciano Marraffini and Jon McGinn. Their combined expertise contributes to the advancement of CRISPR technology and its applications in various fields.

Conclusion

Dominik Paquet is a key figure in the realm of CRISPR gene editing, with a focus on improving the efficiency and accuracy of genetic modifications. His contributions are paving the way for future innovations in genetic research and biotechnology.